BCM
XGN icon

Bridgeway Capital Management’s Exagen XGN Stock Holding History

Bridgeway Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Buy
87,402
+10,202
+13% +$39.5K 0.01% 968
2025
Q4 		$469K Buy
77,200
+49,400
+178% +$450K 0.01% 833
2025
Q3 		$306K Hold
27,800
– – 0.01% 922
2025
Q2 		$194K Buy
27,800
+2,600
+10% +$15.8K ﹤0.01% 967
2025
Q1 		$90.5K Buy
25,200
+4,500
+22% +$17K ﹤0.01% 1055
2024
Q4 		$84.9K Sell
20,700
-1,100
-5% -$3.96K ﹤0.01% 1129
2024
Q3 		$67.4K Hold
21,800
– – ﹤0.01% 1196
2024
Q2 		$39.7K Sell
21,800
-19,000
-47% -$32.2K ﹤0.01% 1236
2024
Q1 		$64.9K Hold
40,800
– – ﹤0.01% 1250
2023
Q4 		$81.2K Hold
40,800
– – ﹤0.01% 1271
2023
Q3 		$100K Sell
40,800
-6,500
-14% -$16.5K ﹤0.01% 1233
2023
Q2 		$137K Hold
47,300
– – ﹤0.01% 1207
2023
Q1 		$115K Hold
47,300
– – ﹤0.01% 1208
2022
Q4 		$114K Hold
47,300
– – ﹤0.01% 1199
2022
Q3 		$128K Hold
47,300
– – ﹤0.01% 1227
2022
Q2 		$272K Sell
47,300
-27,700
-37% -$161K 0.01% 1016
2022
Q1 		$602K Sell
75,000
-12,000
-14% -$103K 0.01% 893
2021
Q4 		$1.01M Hold
87,000
– – 0.02% 788
2021
Q3 		$1.18M Buy
87,000
+9,500
+12% +$126K 0.02% 768
2021
Q2 		$1.16M Buy
77,500
+2,500
+3% +$38.3K 0.02% 809
2021
Q1 		$1.31M Buy
75,000
+1,800
+2% +$32.1K 0.02% 771
2020
Q4 		$966K Hold
73,200
– – 0.02% 755
2020
Q3 		$793K Buy
+73,200
New +$943K 0.02% 746

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Bridgeway Capital Management's XGN Position: Q1 2026 in Review

Bridgeway Capital Management increased its Exagen (XGN) stake by 13% in Q1 2026, buying an estimated $39.5K and bringing the position to 87,402 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #968.

Bridgeway Capital Management first reported a position in XGN in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.31M in Q1 2021. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Bridgeway Capital Management held 87,402 shares of Exagen worth $262K as of Q1 2026.
  • Bridgeway Capital Management bought 10,202 Exagen shares in Q1 2026, an estimated $39.5K.
  • Exagen made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #968 holding.
  • Bridgeway Capital Management first reported a position in Exagen in Q3 2020 and has held it in 23 quarters since.
  • Bridgeway Capital Management's Exagen position peaked at $1.31M in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.